MedWatch Safety Alert

Syndicate content FDA MedWatch
FDA MedWatch Safety Alerts
Updated: 5 hours ago

Pharmacist Choice Alcohol Prep Pads by Simple Diagnostics: Recall - Lack of Sterility Assurance and Other Quality Issues

Tue, 12/05/2017 - 09:00
The use of impacted alcohol prep pads could result in adverse events such as infections.

Limbrel Capsules by Primus Pharmaceuticals: FDA Advisory - Linked to Potentially Life-Threatening Health Problems

Tue, 12/05/2017 - 06:30
UPDATED 12/05/2017. Anyone currently taking Limbrel may be at risk for developing symptoms associated with drug-induced liver injury and/or hypersensitivity pneumonitis.

Albumin Human 25 Percent Solution (AlbuRx 25): Product Information Advisory - Fading Print On Label

Fri, 12/01/2017 - 07:30
Potential for fading print, with more effect on the expiration dating on the patient tear off portion of the vial label.

Bull Capsules, Chao Jimengnan Tablets by Nutra Labs: Recall - Undeclared Drug Ingredients

Fri, 12/01/2017 - 07:10
Undeclared sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening.

Biotin (Vitamin B7): Safety Communication - May Interfere with Lab Tests

Tue, 11/28/2017 - 08:00
Biotin in patient samples can cause falsely high or falsely low results, depending on the test. Incorrect test results may lead to inappropriate patient management or misdiagnosis.

Riomet (Metformin Hydrochloride Oral Solution): Recall - Microbial Contamination

Mon, 11/27/2017 - 09:10
Use of the affected product potentially could result in a risk of infection, especially in an immunocompromised patient.

Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall - Possible Sub Potent and Super Potent Tablets

Thu, 11/16/2017 - 23:00
The use of this product in patients with uncontrolled diarrhea due to chronic medical conditions may predispose the patient to toxicity from either the diphenoxylate or atropine components. Posted 11/17/2017

Nexterone (amiodarone HCl) 150 mg/100 mL Premixed Injection: Recall - Presence Of Particulate Matter

Wed, 11/15/2017 - 12:20
Intravenous administration of a solution containing sterile particulate matter may lead to adverse health consequences.